Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.

Hospital practice (1995)

Volumn 39, Issue 3, 2011, Pages 23-34

  Wilcox, Ryan ^a   Pendleton, Robert C ^b   Smock, Kristi J ^b   Rodgers, George M ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; DABIGATRAN ETEXILATE; ENOXAPARIN; PYRIDINE DERIVATIVE; WARFARIN;

BLOOD CLOTTING TEST; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DOSE RESPONSE; HUMAN; REVIEW; VENOUS THROMBOEMBOLISM;

ANTITHROMBINS; BENZIMIDAZOLES; BLOOD COAGULATION TESTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXAPARIN; HUMANS; PYRIDINES; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 80053433380     PISSN: 21548331     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2011.08.576     Document Type: Review

References (0)